Brazil’s Ministry of Health and ONA have launched the country’s first accreditation manual for digital health, telemedicine, and telehealth services, establishing a formal quality and safety certification pathway for public …
Brazil’s Ministry of Health and ONA have launched the country’s first accreditation manual for digital health, telemedicine, and telehealth services, establishing a formal quality and safety certification pathway for public …
ANVISA has approved serplulimab as the only anti-PD-1 authorized in Brazil for extensive-stage small cell lung cancer, giving Abbott a regulatory head start before larger checkpoint inhibitor rivals.
ANVISA’s approval of the 8th edition of Farmacopeia Brasileira updates national quality standards for medicines and active pharmaceutical ingredients, reshaping registration requirements across Brazil’s pharmaceutical market.
You must be logged in to post a comment.